Saturday, May 4, 2024

University of Nottingham spin-out company named best medtech start-up

University of Nottingham spin-out company Cerca Magnetics was named best start-up medtech company at the annual OBN awards.

Cerca Magnetics received the award in recognition of their achievements developing and bringing to market the first commercial, wearable brain MEG device.

The wearable brain imaging system was developed by researchers at the University of Nottingham and since the formation of Cerca Magnetics 14 months ago has already been installed at the Hospital for Sick Children (SickKids) in Toronto for ground-breaking research into autism, and Young Epilepsy’s diagnostic suite where it is being used to improve how the condition is diagnosed and treated.

The prestigious awards, now in their 13th year, shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches to unmet clinical need, outstanding company progression and the delivery of real-life tangible results.

David Woolger CEO of Cerca said: “We’re delighted to have been awarded best start-up. Since we formed the company, we have had so much interest in this system and are delighted to already be working with Sick Kids and Young Epilepsy to improve the lives of children with brain disorders.”

This wearable brain imaging system is the result of years of research by scientists at the University of Nottingham who recognised the need for an alternative to the conventional MEG scanners that are very expensive, cumbersome, and rely on cryogenic sensors which are not viable for use in infants, and require patients to stay extremely still.

The new wearable system is based upon recently developed “quantum” sensors which use the fundamental properties of atoms to sense local magnetic fields. These new sensors, called optically pumped magnetometers or OPMs, do not require cryogenic cooling. They are also extremely small and lightweight (similar to a Lego brick). This means they can be mounted in a helmet which the patient wears. The helmet can adapt to any head shape or size, and because it is lightweight and moves with the head, it is completely motion robust, making this ideal for children and young people.

Dr Elena Boto, Chief Scientist at Cerca Magnetics said: “It’s incredible to see how far the technology has come since our initial experiments in the lab five years ago. Seeing the system commercialised and installed to help children with neurological problems like autism and epilepsy is amazing and we are looking forward to developing and rolling the system out even further in 2022.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.









Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close